<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="24949">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01769014</url>
  </required_header>
  <id_info>
    <org_study_id>KEK-ZH-Nr.2012-0178</org_study_id>
    <nct_id>NCT01769014</nct_id>
  </id_info>
  <brief_title>Adherence and Quality of Life in People With Schizophrenia and Schizoaffective Disorder</brief_title>
  <official_title>In the Cantons Graubunden and Glarus as Well as in the Principality of Liechtenstein: Influence of Intensive Outpatient Treatment of People With Schizophrenia and Schizoaffective Disorder on Quality of Life and Adherence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Psychiatrische Dienste Graubuenden</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Psychiatrische Dienste Graubuenden</source>
  <oversight_info>
    <authority>Switzerland: Ethikkommission</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      It is the goal of this study adherence and quality of life in a population of people
      suffering from schizophrenia or schizoaffective disorder and to analyze if these factors are
      influenced by treatment, support, social services, and residential treatment. The study
      population is drawn from the the cantons Glarus and Graubunden as well as Liechtenstein.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">April 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Retrospective</study_design>
  <primary_outcome>
    <measure>Quality of life</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Schizophrenia</condition>
  <condition>Schizoaffective Disorder</condition>
  <condition>Quality of Life</condition>
  <eligibility>
    <study_pop>
      <textblock>
        People who suffer from schizophrenia or schizoaffective disorder, following DSM IV
        criteria and who live in the cantons Glarus, Graubuenden or the Principality of
        Liechtenstein.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Schizophrenia or schizoaffective disorder

          -  18 - 65 years old

          -  treated in the PDGR within the past 19 years

        Exclusion Criteria:

          -  organic brain disorder

          -  alcohol or drug dependence

          -  low intelligence

          -  unable to give consent

          -  no legal competency

          -  lacking knowledge of German language

          -  current psychiatric inpatient treatment
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Psychiatrische Dienste Graubuenden</name>
      <address>
        <city>St. Moritz</city>
        <state>Graubuenden</state>
        <zip>7500</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <lastchanged_date>January 15, 2013</lastchanged_date>
  <firstreceived_date>January 14, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>adherence</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Psychotic Disorders</mesh_term>
    <mesh_term>Schizophrenia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
